Introduction
Body builders and athletes use ergogenic supplements extensively to maintain their strength and increase their muscle mass and exercise performance. Many of these supplements have hazardous effects on health if taken without any considerations of the athlete's medical condition or without consulting a physician. One of the most widely used supplements is β-hydroxy-β-methylbutyrate (HMB) (Molfino et al. 2013) .
HMB is a metabolite of the essential branched chain amino acid leucine (Van and Nissen 1992) . HMB supplementation has been found to be useful for weight training athletes, the elderly, or in patients with diseases associated with muscle wasting such as cancer and AIDS (Pinheiro et al. 2013 ). Supplemental HMB is usually taken at a daily dose of 3 grams/day which was found to be safe (Nissen et al. 2000) .
The role of HMB in glucose and insulin homeostasis is controversial. Few reports have emerged showing glucose intolerance and elevation in insulin level after HMB supplementation. For example, glucose intolerance induced by glucocorticoid in Wistar rats was further impaired by co-administration of HMB, while HMB alone did not cause insulin resistance (Nunes et al. 2013 ). This effect was attributed mainly to glucocorticoid effect on lipolysis of adipose tissue (Geer et al. 2014 ). In addition, HMB supplementation for 4 weeks in healthy sedentary Wistar rats reduced glucose tolerance and elevated insulin (Yonamine et al. 2014) . Moreover, HMB supplementation slightly D r a f t 4 increased insulin level after exercise in humans (Townsend et al. 2015) . However, the exact mechanism linking HMB to insulin resistance is still unclear.
Insulin resistance is a condition in which liver, skeletal muscle and adipose tissue fail to respond to the circulating levels of insulin (Virkamaki et al. 1999) . It is associated with obesity, hyperinsulinemia, hyperlipidemia, fatty liver and inflammation (Ye 2013 ).
There are many experimental models to induce insulin resistance among which the use of glucocorticoid, sodium nitrite, high fat diet or high fructose diet (HFD) (AlGayyar et al. 2015; Deer et al. 2015; Su et al. 2014 ). The HFD model is widely used because it mimics the insulin resistance found in human (Bezerra et al. 2000) . It was previously reported that even moderate fructose consumption alters both insulin sensitivity and lipid metabolism (Aeberli et al. 2013 ). Fructose, a lipogenic monosaccharide, is considered a contributor to nearly all of the manifestations of the insulin resistance syndrome (Elliott et al. 2002) .
Since the relation between HMB supplementation and insulin resistance remains controversial, therefore, the present study aimed to investigate the effect of HMB on insulin resistance and the possible underlying mechanisms.
Materials and Methods

Drugs and chemicals
Fructose was purchased from Safety Misr (Cairo, Egypt); HMB (Calcium salt) from Optimum Nutrition (Sunrise, FL, USA); anthrone from Alpha Chemika (Mumbai, India). Acetylcholine hydrochloride (ACh); pentobarbital sodium; phenylephrine hydrochloride (PE) and sodium nitroprusside (SNP) were purchased from Sigma 
Insulin Tolerance Test (ITT)
Twenty-four hours before the end day, animals were fasted for 12 hours and a dose of 0.5 IU/kg human soluble insulin (Actrapid, Novo Nordisk, Bagsvaerd, Denmark) was injected subcutaneously to conscious rats. Blood glucose level was determined at 0, 30, 60, 120 and 180 min after insulin administration. The serum blood glucose level was calculated using a small blood drop from the tail.
Sample preparation
At the end of 12 weeks, the rats were fasted for 12 hours and euthanized using pentobarbital sodium (60 mg/kg, i.p.) and blood samples were collected to prepare serum and heparinized plasma. Liver tissues were immediately collected and snapfrozen in liquid nitrogen, stored at -80°C to be used later for real-time RT-PCR, and glycogen content determination. Another lobe of liver was fixed in 10 % buffered formalin for subsequent histopathological examination. In addition, thoracic aortic rings were isolated for in vitro vascular reactivity measurement.
Determination of fasting serum glucose, insulin and insulin resistance index
The fasting glucose level was measured in serum using an enzymatic colorimetric commercial kit purchased from Biodiagnostic Company (Giza, Egypt). The fasting rat insulin was measured in serum using a rat insulin ELISA kit (Mercodia Developing Diagnostics, Uppsala, Sweden).
Homeostasis model assessment of insulin resistance (HOMA-IR) index was calculated using HOMA2 Calculator, developed by the Diabetes Trial Unit, University of Oxford, Oxford. UK (Levy et al. 1998) .
Estimation of glycosylated hemoglobin (HbA1c)
Glycosylated hemoglobin was determined in whole blood using commercial kit containing cation-exchange resin, according to the manufacturer's instructions (Stanbio Laboratories, TX, USA).
Estimation of liver glycogen content
Liver glycogen content was assessed using the method described by (Seifter et al. 1950 ). The method is based on the digestion of tissue in 30% KOH and precipitating quantitative yield of glycogen with 95% ethanol and saturated sodium sulphate solution.
The glycogen content was estimated by the use of anthrone reagent dissolved in sulphuric acid that causes dehydration of carbohydrates that condenses in the presence of anthrone to produce bluish green color measured at 620 nm and glycogen was expressed as mg/100g tissue.
Measurement of lipid profile in serum
Serum triglycerides (TG) and total cholesterol (TC) were estimated in serum using commercial kits (Spinreact, Santa Coloma, Spain) according to manufacturer's instructions. High density lipoprotein cholesterol (HDL-C) was estimated in serum using commercial kit (Vitro Scient., Hannover, Germany). Low density lipoprotein cholesterol (LDL-C) and very low density lipoprotein cholesterol (VLDL-C) were determined according to the following equations: VLDL-C=TG/5 while LDL-C= TC-[VLDL-C + HDL-C] (Yadav et al. 2007 ).
Determination of in vitro vascular reactivity
The descending thoracic aorta was isolated and rapidly placed in cold oxygenated physiological salt solution of the following composition (mmol/L): NaCl 118, KCl 4.7, CaCl 2 2.5, and MgSO 4 ·7H 2 O 1.2, KH 2 PO 4 1.2, glucose 11.1 and NaHCO 3 D r a f t 8 25; pH 7.4, then the aorta was dissected free of fat and connective tissue, and cut into rings (2-4 mm) each.
Each aortic ring was mounted between two stainless steel hooks in a 10 ml organ bath at 37 °C and was filled with physiological salt solution which was aerated with a mixture of 95% O 2 and 5% CO 2 .The aortic ring was allowed to equilibrate under 1 g of force for 60 minutes during which the physiological solution was changed every 15 minutes. Vascular reactivity was measured using Riegestab K30 force transducer The results were expressed as an n-fold change of the relative expression levels of target genes from control group using ∆∆C t method.
Histopathological examination:
The 10% buffered formalin fixed liver tissue was embedded in paraffin wax, sectioned (6 µm) and stained with hematoxylin-eosin (H&E) and samples were assessed for the presence of steatosis microscopically (Leica Imaging Systems, Cambridge, UK).
The hepatic steatosis was evaluated by semiquantitative scale from 0 to 3; 0= no steatosis, 1= mild steatosis less than 33%, 2=moderate steatosis more than 33% and less than 66% and 3=severe steatosis more than 66%. The pathologist performing histopathological evaluation was blinded to the study treatment assignment.
Statistical analysis:
Data are expressed as mean ± standard error of mean (SEM). Statistical analysis and graphing were carried out using GraphPad software Prism V 5.02 (GraphPad D r a f t Software Inc., San Diego, CA, USA). Vascular relaxation was calculated as percentage of the maximal contraction induced by 1 µM PE. The highest response obtained was considered as the maximum response (E max ) and pEC 50 (negative log of the concentration producing 50% of maximal response) was determined from non-linear regression analysis (four-parameter curve fit). One-way analysis of variance (ANOVA) followed by Tukey-Kramer's multiple comparisons post-hoc test were used to measure significant differences between groups. Statistical significance was considered at p<0.05. Histopathological steatosis scoring was compared using Kruskal-Wallis followed by Dunn's multiple comparison test.
Results
Effect of HMB on HFD-induced changes in body weight gain and mean daily food intake in rats
The body weight gain and mean food intake were not significantly altered among groups after 12 weeks (Table 1) .
Effect of HMB on HFD-induced changes in OGTT and ITT
The HFD caused a significant (p<0.05, n=8) increase in area under the curve (AUC) of blood glucose level in OGTT by 113% compared to the control group ( Figure   1 ). HMB treatment did not significantly reduce HFD-induced increase in AUC. 
Effect of HMB on HFD-induced changes in liver glycogen content
Liver glycogen content was significantly (p<0.05, n=8) elevated by HFD by 207 % compared to the control group (Figure 1 ).
Treatment with HMB in HFD rats from week 9 to 12 managed to decrease liver glycogen content significantly (p<0.05, n=8), which was reduced by 43 % compared HFD group. HMB treatment had no significant effect on liver glycogen content in control animals.
Effect of HMB on HFD-induced changes in lipid profile in serum
The HFD caused a significant (p<0.05, n=8) increase in TG, LDL-C and VLDL-C levels by 318 %, 638 % and 297 % respectively ( Figure 2 ) and it caused a significant decrease in HDL-C level by 19 % compared to the control group, while TC level wasn't significantly affected by HFD.
Treatment with HMB significantly (p<0.05, n=8) decreased the HFD-induced elevated levels of TG, LDL-C and VLDL-C levels, which was decreased by 67 % , 72 % and 64 % respectively compared to HFD group, while, it did not attenuate the decreased level of HDL-C. HMB treatment had no significant effect on lipid profile in control rats.
Effect of HMB on HFD-induced changes in vascular reactivity in vitro
The HFD had no significant effect on KCl or PE-induced contraction or SNPinduced relaxation in aortic rings ( Figure 3 ) when compared to control group. On the other hand, HFD caused a significant (p<0.05, n=6) decrease in endothelium-dependent ACh-induced maximal relaxation, where the (E max ) decreased significantly by 57 % compared to control group, however, it had no significant effect on pEC 50 .
HMB in HFD rats significantly (p<0.05, n=6) enhanced vascular reactivity by increasing ACh-induced maximal relaxation (E max ), which increased by 205 % compared to the HFD group. HMB treatment had no significant effect on vascular reactivity in control rats. 
Effect of HMB on
Effect of HMB on HFD-induced changes in histopathology
Liver specimen (n=6) of control group showed normal hepatic architecture with normal hepatocytes arranged in 1-2 thickness plates with no evidence of steatosis, with mean score=0.33 ( Figure 5A ), while HFD rats showed severe steatosis affecting >66% of hepatocytes mainly periportal (microvesicular and macrovesicular steatosis), with mean score=2.67 ( Figure 5B ). Treatment with HMB in HFD rats showed minimal steatosis (15 % of hepatocytes) showing both microvesicular and macrovesicular steatosis, with mean score=1 ( Figure 5D ). HMB treatment in normal rats showed normal hepatocytes radiating from central veins with no evidence of steatosis, with mean score=0.33 ( Figure 5C ).
Discussion
In this study, feeding rats with HFD for 12 weeks showed a decline in insulin sensitivity which was shown by the impaired insulin and glucose tolerance. The state of insulin resistance was confirmed by elevated levels of fasting insulin, fasting glucose, into hepatic cells as a major precursor for lipogenesis in our model. Therefore, HMB may attenuate dyslipidemia and hepatic steatosis through its effect on GLUT-2.
Insulin signaling is inhibited by the intermediates produced during TG synthesis as mTOR, protein kinase-C (PKC) and ceramide (Nagle et al. 2009 ). PKC and mTOR affect the phosphorylation of insulin receptor substrate-1 (IRS-1) that is accompanied by an impaired association between IRS-1 and PI3K (Gual et al. 2005) , preventing PI3K
activation (Li et al. 1999; Moeschel et al. 2004 ). Ceramide inhibits Akt-mediated insulin signaling resulting in insulin resistance.
In this study treatment with HMB for 4 weeks reduced insulin resistance, HOMA-IR index and increased insulin tolerance, without affecting mTOR mRNA expression. However, previous study has shown that mTOR expression in skeletal muscle increases after HMB consumption in a model of skeletal muscle hypertrophy in rats, this discrepancy may be due to the difference in the model and the difference in mTOR expression in skeletal muscle than in liver (Pimentel et al. 2011) .
HMB was previously shown to stimulate PI3K/Akt pathway involved in insulin signaling (Kornasio et al. 2009 ). This effect of HMB may be related to its attenuating effect on dyslipidemia, where decreasing TG intermediates will subsequently enhance insulin signaling.
Insulin resistance is also characterized by impaired endothelial-dependent negative log of the concentration producing 50% of maximal response. 
